Castle Creek Pharmaceuticals Receives Partners in Progress Award from debra of America

Castle Creek Pharmaceuticals (CCP), a global company dedicated to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, today announced that the company received the Partners in Progress Award at the 19th Annual debra of America (Dystrophic Epidermolysis Bullosa Research Association of America) Benefit held October 26, 2017 at Guastavino’s in New York City.

Read More
Jennifer Murphy